Rehabilitation remains a cornerstone in the management of PMP22 gene-related neuropathies. Supportive therapeutic approaches are central to patient care and are contributing to developments within the Peripheral Myelin Protein 22 (PMP22) Gene-Related Disorder Market.

Because these disorders cause progressive muscle weakness and balance difficulties, physical therapy focuses on maintaining strength, flexibility, and coordination. Customized exercise programs help prevent muscle atrophy and improve mobility. Low-impact activities such as swimming and cycling are often recommended to minimize joint strain.

Occupational therapy plays a complementary role by assisting patients in adapting to daily tasks. Assistive devices, ergonomic tools, and adaptive techniques enable individuals to maintain independence. Orthotic devices, including ankle-foot orthoses, help stabilize weakened muscles and reduce fall risk.

Early rehabilitation intervention is especially important in pediatric cases. Children diagnosed with CMT1A can benefit from structured therapy programs designed to preserve function during growth and development. Regular monitoring ensures timely adjustments to therapy plans.

As rehabilitation science advances, innovative approaches such as robotic-assisted therapy and neuromuscular stimulation are being explored. These technologies may further enhance muscle activation and functional recovery.

Comprehensive rehabilitation strategies significantly improve quality of life and help patients maintain active lifestyles despite progressive nerve impairment.